139 related articles for article (PubMed ID: 11443870)
1. Antibody interactions with rhinovirus: lessons for mechanisms of neutralization and the role of immunity in viral evolution.
Smith TJ
Curr Top Microbiol Immunol; 2001; 260():1-28. PubMed ID: 11443870
[No Abstract] [Full Text] [Related]
2. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
Smith TJ; Chase ES; Schmidt TJ; Olson NH; Baker TS
Nature; 1996 Sep; 383(6598):350-4. PubMed ID: 8848050
[TBL] [Abstract][Full Text] [Related]
3. Structure determination of an Fab fragment that neutralizes human rhinovirus 14 and analysis of the Fab-virus complex.
Liu H; Smith TJ; Lee WM; Mosser AG; Rueckert RR; Olson NH; Cheng RH; Baker TS
J Mol Biol; 1994 Jul; 240(2):127-37. PubMed ID: 8027997
[TBL] [Abstract][Full Text] [Related]
4. Structural studies on antibody interacting with viruses.
Hewat E; Blaas D
Curr Top Microbiol Immunol; 2001; 260():29-44. PubMed ID: 11443879
[No Abstract] [Full Text] [Related]
5. Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2.
Tormo J; Blaas D; Parry NR; Rowlands D; Stuart D; Fita I
EMBO J; 1994 May; 13(10):2247-56. PubMed ID: 8194515
[TBL] [Abstract][Full Text] [Related]
6. Structure of a human rhinovirus-bivalently bound antibody complex: implications for viral neutralization and antibody flexibility.
Smith TJ; Olson NH; Cheng RH; Chase ES; Baker TS
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7015-8. PubMed ID: 8394005
[TBL] [Abstract][Full Text] [Related]
7. Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody.
Smith TJ; Olson NH; Cheng RH; Liu H; Chase ES; Lee WM; Leippe DM; Mosser AG; Rueckert RR; Baker TS
J Virol; 1993 Mar; 67(3):1148-58. PubMed ID: 7679742
[TBL] [Abstract][Full Text] [Related]
8. Recent structural solutions for antibody neutralization of viruses.
Stewart PL; Nemerow GR
Trends Microbiol; 1997 Jun; 5(6):229-33. PubMed ID: 9211643
[TBL] [Abstract][Full Text] [Related]
9. Docking of a human rhinovirus neutralizing antibody onto the viral capsid.
Tormo J; Centeno NB; Fontana E; Bubendorfer T; Fita I; Blaas D
Proteins; 1995 Dec; 23(4):491-501. PubMed ID: 8749845
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes.
Che Z; Olson NH; Leippe D; Lee WM; Mosser AG; Rueckert RR; Baker TS; Smith TJ
J Virol; 1998 Jun; 72(6):4610-22. PubMed ID: 9573224
[TBL] [Abstract][Full Text] [Related]
11. Minute virus of mice, a parvovirus, in complex with the Fab fragment of a neutralizing monoclonal antibody.
Kaufmann B; López-Bueno A; Mateu MG; Chipman PR; Nelson CD; Parrish CR; Almendral JM; Rossmann MG
J Virol; 2007 Sep; 81(18):9851-8. PubMed ID: 17626084
[TBL] [Abstract][Full Text] [Related]
12. Flexibility of the major antigenic loop of foot-and-mouth disease virus bound to a Fab fragment of a neutralising antibody: structure and neutralisation.
Verdaguer N; Schoehn G; Ochoa WF; Fita I; Brookes S; King A; Domingo E; Mateu MG; Stuart D; Hewat EA
Virology; 1999 Mar; 255(2):260-8. PubMed ID: 10069951
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.
Tormo J; Stadler E; Skern T; Auer H; Kanzler O; Betzel C; Blaas D; Fita I
Protein Sci; 1992 Sep; 1(9):1154-61. PubMed ID: 1338980
[TBL] [Abstract][Full Text] [Related]
14. Nonneutralizing human rhinovirus serotype 2-specific monoclonal antibody 2G2 attaches to the region that undergoes the most dramatic changes upon release of the viral RNA.
Hewat EA; Blaas D
J Virol; 2006 Dec; 80(24):12398-401. PubMed ID: 17005641
[TBL] [Abstract][Full Text] [Related]
15. Structure of human rhinovirus serotype 2 (HRV2).
Verdaguer N; Blaas D; Fita I
J Mol Biol; 2000 Jul; 300(5):1179-94. PubMed ID: 10903863
[TBL] [Abstract][Full Text] [Related]
16. Structure of a neutralizing antibody bound monovalently to human rhinovirus 2.
Hewat EA; Marlovits TC; Blaas D
J Virol; 1998 May; 72(5):4396-402. PubMed ID: 9557730
[TBL] [Abstract][Full Text] [Related]
17. Different rhinovirus serotypes neutralized by antipeptide antibodies.
McCray J; Werner G
Nature; 1987 Oct 22-28; 329(6141):736-8. PubMed ID: 2444889
[TBL] [Abstract][Full Text] [Related]
18. Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.
Nelson CD; Palermo LM; Hafenstein SL; Parrish CR
Virology; 2007 May; 361(2):283-93. PubMed ID: 17217977
[TBL] [Abstract][Full Text] [Related]
19. A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment.
Lee H; Brendle SA; Bywaters SM; Guan J; Ashley RE; Yoder JD; Makhov AM; Conway JF; Christensen ND; Hafenstein S
J Virol; 2015 Jan; 89(2):1428-38. PubMed ID: 25392224
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments.
Colonno RJ; Callahan PL; Leippe DM; Rueckert RR; Tomassini JE
J Virol; 1989 Jan; 63(1):36-42. PubMed ID: 2535737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
